Resources Topic: IV Insulin

video Improved Patient Safety and Glycemic Outcomes in the ICU Using Computer-Guided Intravenous Insulin Therapy Versus Subcutaneous Insulin Therapy Presenter: Alexandria Hall, PharmD | Grady Hospital Watch the video today! hbspt.forms.create({ portalId: “5011756”, formId: “4bcb3b24-2af9-4575-a353-d31e2f9f5197”, sfdcCampaignId: “7010d000000mvNIAAY” }); Learn how Grady Hospital: Compared continuous IV insulin to subcutaneous insulin use for hyperglycemic patients Evaluated ICU protocols on rates of hypoglycemia …

Technology Reduces the #1 Adverse Medication Safety Events in the Hospital – Debra Dudley, RN

Utilization of eGMS® Decreases Hypoglycemia Adverse Drug Events, LOS and Costs – Jamie Casanova, PharmD

Sustained Hypoglycemia Reduction with IV insulin via eGMS® – Barbara McLean, MN, RN

Improved Patient Safety and Glycemic Outcomes in the ICU Using Computer-Guided Intravenous Insulin Therapy Versus Subcutaneous Insulin Therapy

Reduction of Hospital Hypoglycemia with eGMS and Quality Programming Across 180 US Hospitals

Insulin Management and COVID-19 Resources

U.S. Survey of Healthcare Professionals: Inpatient Diabetes Care and Glycemic Management. Focus on Insulin Therapy and Hypoglycemia.

Clinicians and Patients Speak to the Efficacy, Safety and Value of Glytec’s eGlycemic Management System.

Clinical and financial impact of inpatient diabetes care and glycemic management in the ICU and Non-ICU. Dr. Guillermo Umpierrez of Emory University and Grady Health.

Improvements in quality and safety of patient care through changes to insulin management protocols, including the transition from Monarch Medical Technologies’ EndoTool to Glytec’s Glucommander. MedPage Today interviews Dr. Valerie Garrett.

Clinical and financial outcomes of intensive glucose control for cardiac surgery patients, including results of the GLUCO-CABG Trial. Dr. Guillermo Umpierrez of Emory University and Grady Health.

Use of Glucommander for management and resolution of diabetic ketoacidosis in hospitalized patients. MedPage Today interviews Dr. Guillermo Umpierrez.

A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, operations perspective. Audrey Douglas-Cooke, Vice President Operations and Associate Nursing Executive.

A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, executive perspective. Dr. Paul Chidester, Vice President Medical Affairs, and Dr. H. Courtenay Harrison, Jr., Medical Director Diabetes Center.

A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, nursing perspective. Margaret Bachand, Diabetes Center Manager; Evelyn Olenick, Vice President Patient Care Services; and Grace Pagtakhan, former Clinical Nurse II.

Comparing Glucommander IV to usual care for treatment of diabetic ketoacidosis. Diabetes in Control interviews Dr. Joseph Aloi.

Use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing Monarch Medical Technologies’ EndoTool with Glytec’s Glucommander. MD Magazine interviews Dr. Valerie Garrett.

Use of Glucommander to prevent medication errors involving insulin. Diabetes in Control interviews Dr. Joseph Aloi.